• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前的端口维护策略并不充分:基于植入端口的实际表现的观点。

Current port maintenance strategies are insufficient: View based on actual presentations of implanted ports.

作者信息

Chou Pin-Li, Fu Jui-Ying, Cheng Chia-Hui, Chu Yen, Wu Ching-Feng, Ko Po-Jen, Liu Yun-Hen, Wu Ching-Yang

机构信息

Chang Gung University, Taiwan.

Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan.

出版信息

Medicine (Baltimore). 2019 Nov;98(44):e17757. doi: 10.1097/MD.0000000000017757.

DOI:10.1097/MD.0000000000017757
PMID:31689833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6946320/
Abstract

Nursing staff play a crucial role in maintaining a functional port. Nursing guidelines recommend standard maintenance with 10 ml irrigation without consideration for variations among patients and individual nursing staff. The aim of this study is to identify the efficacy of the current maintenance strategy and analyze the correlation between complications and actual port presentations, based on disassembled intravenous ports after removal from patients. We attempt to organize the information and propose a definite maintenance strategy.After treatment completion, or due to complications, 434 implanted intravenous ports were removed from patients. All ports were deconstructed to observe their actual presentations and were then analyzed in conjunction with medical records. The correlation between complications and actual presentations was analyzed.From March 2012 to December 2017, 434 implanted intravenous ports were removed from oncology patients after completion of treatment or catheter related complications. From the view of maintenance related presentations, injection chamber blood clot was highly correlated with chemotherapy completion (P < .001) and malfunction (P = .005), while tip blood clot (P = .043) was related with chemotherapy completion and catheter fibrin (P = .015) was related to malfunction. From the view of structure related presentations, broken catheter integrity was correlated to chemotherapy completion (P = .007), fracture (P < .001), and malfunction (P = .008). Compression groove was related to chemotherapy completion (P = .03) and broken catheter at protruding stud was related to fracture (P = .04), while diaphragm rupture was correlated to chemotherapy completion (P = .048) and malfunction. (P < .001).Current port maintenance is insufficient for ideal port maintenance, whereby maintenance-related presentations, including tip clot, catheter fibrin, and injection chamber blood clot were identified. We propose a recommended maintenance strategy based on our findings. Structure-related presentations, including broken catheter integrity, broken catheter at protruding stud and diaphragm rupture were seen in patients with longer implantation period. Removal of the implanted port may be considered after 5 years if no disease relapse is noted.

摘要

护理人员在维持功能性端口方面发挥着关键作用。护理指南建议采用10毫升冲洗液进行标准维护,而不考虑患者和个体护理人员之间的差异。本研究的目的是基于从患者身上移除的拆解后的静脉端口,确定当前维护策略的有效性,并分析并发症与实际端口表现之间的相关性。我们试图整理这些信息并提出明确的维护策略。治疗完成后,或因并发症,从患者身上移除了434个植入的静脉端口。所有端口均被拆解以观察其实际表现,然后结合病历进行分析。分析了并发症与实际表现之间的相关性。2012年3月至2017年12月,在治疗完成或发生导管相关并发症后,从肿瘤患者身上移除了434个植入的静脉端口。从维护相关表现来看,注射腔血栓与化疗完成情况(P<0.001)和功能障碍(P=0.005)高度相关,而尖端血栓(P=0.043)与化疗完成情况相关,导管纤维蛋白(P=0.015)与功能障碍相关。从结构相关表现来看,导管完整性破损与化疗完成情况(P=0.007)、断裂(P<0.001)和功能障碍(P=0.008)相关。压缩槽与化疗完成情况(P=0.03)相关,突出螺柱处的导管破损与断裂(P=0.04)相关,而隔膜破裂与化疗完成情况(P=0.048)和功能障碍(P<0.001)相关。当前的端口维护不足以实现理想的端口维护,由此确定了与维护相关的表现,包括尖端血栓、导管纤维蛋白和注射腔血栓。我们根据研究结果提出了推荐的维护策略。在植入时间较长的患者中观察到了与结构相关的表现,包括导管完整性破损、突出螺柱处的导管破损和隔膜破裂。如果未发现疾病复发,可考虑在5年后移除植入的端口。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/f39b52972e50/medi-98-e17757-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/74166f1793ae/medi-98-e17757-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/3e6c30ef8dae/medi-98-e17757-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/7b411cec3f09/medi-98-e17757-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/f587b5b4afd0/medi-98-e17757-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/f39b52972e50/medi-98-e17757-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/74166f1793ae/medi-98-e17757-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/3e6c30ef8dae/medi-98-e17757-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/7b411cec3f09/medi-98-e17757-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/f587b5b4afd0/medi-98-e17757-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c710/6946320/f39b52972e50/medi-98-e17757-g005.jpg

相似文献

1
Current port maintenance strategies are insufficient: View based on actual presentations of implanted ports.当前的端口维护策略并不充分:基于植入端口的实际表现的观点。
Medicine (Baltimore). 2019 Nov;98(44):e17757. doi: 10.1097/MD.0000000000017757.
2
Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.用于长期化疗的完全植入式中心静脉通路导管。一项前瞻性研究,分析333个装置的并发症和成本,最短随访期为180天。
Ann Oncol. 1998 Jul;9(7):767-73. doi: 10.1023/a:1008392423469.
3
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.用于实体瘤化疗的、连接到Groshong导管的长期完全植入式中心静脉通路端口:178例使用单一类型装置的经验
Eur J Cancer. 1997 Jul;33(8):1190-4. doi: 10.1016/s0959-8049(97)00039-7.
4
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.妇科恶性肿瘤化疗患者使用低剖面皮下植入式静脉通路装置的机械故障发生率。
Gynecol Oncol. 2011 Oct;123(1):54-7. doi: 10.1016/j.ygyno.2011.06.012. Epub 2011 Jul 13.
5
Analysis of chest X-ray plain film images of intravenous ports inserted via the superior vena cava.经上腔静脉置入静脉输液港的胸部X线平片图像分析。
Surg Today. 2014 Aug;44(8):1513-21. doi: 10.1007/s00595-014-0893-5. Epub 2014 Apr 9.
6
A comparative analysis of infection and complication rates between single- and double-lumen ports.单腔与双腔端口的感染和并发症发生率比较分析。
Infect Control Hosp Epidemiol. 2024 Jun;45(6):698-702. doi: 10.1017/ice.2024.1. Epub 2024 Jan 26.
7
Management of Port Occlusions in Adults: Different-Site Replacement versus Same-Site Salvage.成人端口闭塞的管理:不同部位替换与同一部位挽救。
J Vasc Interv Radiol. 2019 Jul;30(7):1069-1074. doi: 10.1016/j.jvir.2019.02.027. Epub 2019 May 24.
8
Efficacy and clinical outcome of the port-a-cath in children: a tertiary care-center experience.经外周静脉置入中心静脉导管(PICC)在儿童中的疗效和临床结局:一家三级护理中心的经验。
World J Surg Oncol. 2020 Jun 19;18(1):134. doi: 10.1186/s12957-020-01912-w.
9
Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.用于前臂植入式中心静脉导管装置的聚氨酯导管与硅胶导管的比较
Eur J Cancer. 2016 May;59:113-124. doi: 10.1016/j.ejca.2016.02.011. Epub 2016 Mar 26.
10
Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.对于早期乳腺癌患者,在上臂植入全植入式静脉通路端口是可行且安全的。
J Vasc Access. 2020 Sep;21(5):609-614. doi: 10.1177/1129729819894461. Epub 2019 Dec 16.

引用本文的文献

1
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.肿瘤学中中央静脉通路装置的术语、并发症和移除原因:范围综述。
BMC Cancer. 2024 Apr 19;24(1):498. doi: 10.1186/s12885-024-12099-8.
2
Double pigtail catheter reduction for seriously displaced intravenous infusion port catheter: A case report.双猪尾导管复位严重移位的静脉输液港导管:一例报告
World J Clin Cases. 2023 Feb 6;11(4):883-887. doi: 10.12998/wjcc.v11.i4.883.
3
[Surgical complications of totally implantable venous access port in children with malignant tumors].

本文引用的文献

1
Infusion Therapy Standards of Practice, 8th Edition.《输液治疗实践标准》第8版
J Infus Nurs. 2021;44(1S Suppl 1):S1-S224. doi: 10.1097/NAN.0000000000000396.
2
Recommended irrigation volume for an intravenous port: Ex vivo simulation study.推荐的静脉港冲洗容量:离体模拟研究。
PLoS One. 2018 Aug 14;13(8):e0201785. doi: 10.1371/journal.pone.0201785. eCollection 2018.
3
Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report.肿瘤学实践中的端口:每3个月用生理盐水封管以维护导管,初步报告。
[完全植入式静脉输液港在儿童恶性肿瘤患者中的手术并发症]
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Dec 18;54(6):1167-1171. doi: 10.19723/j.issn.1671-167X.2022.06.018.
4
Does catheter material affect functional performance of intravenous ports via the superior vena cava?导管材料是否通过上腔静脉影响静脉港的功能性能?
PLoS One. 2021 Oct 27;16(10):e0253818. doi: 10.1371/journal.pone.0253818. eCollection 2021.
5
Comparing the Effects of Pulsatile and Continuous Flushing on Time and Type of Peripheral Intravenous Catheters Patency: A Randomized Clinical Trial.比较脉冲式冲洗与持续冲洗对外周静脉导管通畅时间和类型的影响:一项随机临床试验。
J Caring Sci. 2021 May 24;10(2):84-88. doi: 10.34172/jcs.2021.016. eCollection 2021 May.
6
Long-Term Results of a Standard Algorithm for Intravenous Port Implantation.静脉输液港植入标准算法的长期结果
J Pers Med. 2021 Apr 24;11(5):344. doi: 10.3390/jpm11050344.
7
Long-Term Follow-Up and Clinical Relevance of Incidental Findings of Fibrin Sheath and Thrombosis on Computed Tomography Scans of Cancer Patients with Port Catheters.携带植入式静脉输液港的癌症患者计算机断层扫描中纤维蛋白鞘和血栓偶然发现的长期随访及临床相关性
Ther Clin Risk Manag. 2021 Jan 27;17:111-118. doi: 10.2147/TCRM.S287544. eCollection 2021.
J Vasc Access. 2017 Jul 14;18(4):325-327. doi: 10.5301/jva.5000740. Epub 2017 Jun 20.
4
Initial experiences with a new design for a preattached intravenous port device.一种新型预附式静脉港装置的初步应用经验。
J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):1017-1027. doi: 10.1002/jbm.b.33911. Epub 2017 May 8.
5
Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports.用于植入完全植入式静脉通路端口的静脉切开术与塞丁格技术的比较
Cochrane Database Syst Rev. 2016 Aug 21;2016(8):CD008942. doi: 10.1002/14651858.CD008942.pub2.
6
Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children: A systematic review.肝素与 0.9%氯化钠间断冲洗预防婴幼儿长期中心静脉导管堵塞的系统评价。
Int J Nurs Stud. 2016 Jul;59:51-9. doi: 10.1016/j.ijnurstu.2016.02.014. Epub 2016 Mar 4.
7
Incidence and Determinants of Port Occlusions in Cancer Outpatients: A Prospective Cohort Study.癌症门诊患者门静脉闭塞的发生率及影响因素:一项前瞻性队列研究。
Cancer Nurs. 2017 Mar/Apr;40(2):102-107. doi: 10.1097/NCC.0000000000000357.
8
Central venous access in oncology: ESMO Clinical Practice Guidelines.肿瘤学中的中心静脉通路:ESMO临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v152-68. doi: 10.1093/annonc/mdv296.
9
The Treatment Results of a Standard Algorithm for Choosing the Best Entry Vessel for Intravenous Port Implantation.一种用于选择静脉输液港植入最佳入路血管的标准算法的治疗结果
Medicine (Baltimore). 2015 Aug;94(33):e1381. doi: 10.1097/MD.0000000000001381.
10
Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit.静脉导管的封管与冲管:现有证据及证据不足情况
Nurs Res Pract. 2015;2015:985686. doi: 10.1155/2015/985686. Epub 2015 May 14.